Evidence map›Paper›PMID 40158291›Full record

ArticleInternational journal of pharmaceutics2025

Corrigendum to "An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable" [Int. J. Pharm. 673 (2025) 125372].

Fatemah S Sunbul, Rashed M Almuqbil, Hanming Zhang, Sulaiman S Alhudaithi, Matthew E Fernandez, Raneem R Aldaqqa, Victoria A Garcia, Valentina Robila, Matthew S Halquist, Sarah W Gordon and 2 more

Abstract readPublished Erratum
In one paragraph

Article in International journal of pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Fatemah S SunbulDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America; Center for Pharmaceutical Engineering and Sciences - School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America.
Rashed M AlmuqbilDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America.
Hanming ZhangDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America.
Sulaiman S AlhudaithiDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America.
Matthew E FernandezDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America; Center for Pharmaceutical Engineering and Sciences - School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America.
Raneem R AldaqqaDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America; Center for Pharmaceutical Engineering and Sciences - School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America.
Victoria A GarciaDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America; Center for Pharmaceutical Engineering and Sciences - School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America.
Valentina RobilaDepartment of Pathology - School of Medicine, Virginia Commonwealth University, Richmond, VA, the United States of America.
Matthew S HalquistDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America; Center for Pharmaceutical Engineering and Sciences - School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America.
Sarah W GordonDepartment of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA, the United States of America.
Paula D BosCenter for Pharmaceutical Engineering and Sciences - School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America; Department of Pathology - School of Medicine, Virginia Commonwealth University, Richmond, VA, the United States of America; Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA, the United States of America.
Sandro R P da RochaDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America; Center for Pharmaceutical Engineering and Sciences - School of Pharmacy, Virginia Commonwealth University, Richmond, VA, the United States of America; Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA, the United States of America. Electronic address: srdarocha@vcu.edu.

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Keri R Maher · 1985 to 2026
$51.0M
Regulatory T cell modulation of reactive astrogliosis in brain metastasisR37CA269249 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Paula Daniela Bos · 2022 to 2026
$2.1M
Integrative Training Program in Cancer BiologyT32CA272382 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Paula Daniela Bos · 2023 to 2026
$1.3M
Shifting the immune infiltrates in osteosarcoma lung metastases with locally targeted CSF-1Ris for combination therapiesR21CA259969 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI DA ROCHA, SANDRO R. P. · 2021 to 2021
$399k
NCI NIH HHS P30 CA016059NCI NIH HHS R21 CA259969NCI NIH HHS R37 CA269249NCI NIH HHS T32 CA272382
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40158291
PMCPMC13134802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.